4//SEC Filing
Kemble George 4
Accession 0001104659-23-099310
CIK 0001400118other
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 4:15 PM ET
Size
6.9 KB
Accession
0001104659-23-099310
Insider Transaction Report
Form 4
Kemble George
DirectorExecutive Chairman
Transactions
- Exercise/Conversion
Series A Common Stock
2023-09-07$0.79/sh+5,630$4,448→ 5,630 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-09-07−5,630→ 0 totalExercise: $0.79Exp: 2023-09-26→ Series A Common Stock (5,630 underlying)
Footnotes (1)
- [F1]This option is fully vested and exercisable as of the date hereof.
Documents
Issuer
Sagimet Biosciences Inc.
CIK 0001400118
Entity typeother
Related Parties
1- filerCIK 0001858176
Filing Metadata
- Form type
- 4
- Filed
- Sep 7, 8:00 PM ET
- Accepted
- Sep 8, 4:15 PM ET
- Size
- 6.9 KB